BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2152849)

  • 1. Histopathologic features of hepatocellular carcinoma in Zaire.
    Kashala LO; Conne B; Kalengayi MM; Kapanci Y; Frei PC; Lambert PH
    Cancer; 1990 Jan; 65(1):130-4. PubMed ID: 2152849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma. A study of 50 autopsy cases with detection of hepatitis B surface antigen in fixed tissues.
    Perez-Barrios A; Colina-Ruizdelgado F; Gallego I; Martinez-Tello FJ
    Pathol Res Pract; 1983 Mar; 176(2-4):131-44. PubMed ID: 6190153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
    Szczepański W
    Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic study on hepatocellular carcinoma negative for hepatitis B surface antigen and antibody to hepatitis C virus.
    Noguchi K; Nakashima O; Nakashima Y; Shiota K; Nawata H; Kojiro M
    Int J Mol Med; 2000 Dec; 6(6):661-5. PubMed ID: 11078825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of hepatocellular carcinoma in Shikoku, Japan: a study of 198 autopsy cases in Tokushima and Ehime Prefectures.
    Akagi G; Furuya K; Otsuka H; Tao S; Moriwaki S
    Jpn J Cancer Res; 1988 Jan; 79(1):25-31. PubMed ID: 2833481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related, different clinicopathologic features of hepatocellular carcinoma patients.
    Namieno T; Kawata A; Sato N; Kondo Y; Uchino J
    Ann Surg; 1995 Mar; 221(3):308-14. PubMed ID: 7536406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical detection of ras oncogene p21 product in liver cirrhosis and hepatocellular carcinoma.
    Nonomura A; Ohta G; Hayashi M; Izumi R; Watanabe K; Takayanagi N; Mizukami Y; Matsubara F
    Am J Gastroenterol; 1987 Jun; 82(6):512-8. PubMed ID: 3034055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
    Mwangi J; Gatei DG
    East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is mallory body formation a preneoplastic change? A study of 181 cases of liver bearing hepatocellular carcinoma and 82 cases of cirrhosis.
    Nakanuma Y; Ohta G
    Cancer; 1985 May; 55(10):2400-4. PubMed ID: 2985233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleolar hypertrophy correlates with hepatocellular carcinoma development in cirrhosis due to HBV infection.
    Trerè D; Borzio M; Morabito A; Borzio F; Roncalli M; Derenzini M
    Hepatology; 2003 Jan; 37(1):72-8. PubMed ID: 12500191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathomorphologic comparison of hepatitis C virus-related and hepatitis B virus-related cirrhosis bearing hepatocellular carcinoma.
    Kojiro M; Shimamatsu K; Kage M
    Princess Takamatsu Symp; 1995; 25():179-84. PubMed ID: 8875623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver cell dysplasia in association with hepatocellular carcinoma, cirrhosis and hepatitis B surface antigen in Hong Kong.
    Ho JC; Wu PC; Mak TK
    Int J Cancer; 1981 Nov; 28(5):571-4. PubMed ID: 6273339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma in the U.S.A., etiologic considerations. Localization of hepatitis B antigens.
    Omata M; Ashcavai M; Liew CT; Peters RL
    Gastroenterology; 1979 Feb; 76(2):279-87. PubMed ID: 215488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor.
    Ruà S; Comino A; Fruttero A; Torchio P; Bouzari H; Taraglio S; Torchio B; Capussotti L
    Cancer; 1996 Sep; 78(6):1195-202. PubMed ID: 8826940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan.
    Yu MW; Chang HC; Chen PJ; Liu CJ; Liaw YF; Lin SM; Lee SD; Lin SC; Lin CL; Chen CJ
    Int J Epidemiol; 2002 Oct; 31(5):1008-15. PubMed ID: 12435776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients.
    Nzeako UC; Goodman ZD; Ishak KG
    Am J Clin Pathol; 1996 Jan; 105(1):65-75. PubMed ID: 8561091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of ras oncogene p21 product and proliferating cell nuclear antigen in liver cirrhosis and the correlation with liver cell dysplasia].
    Feng Z; He R; Lu Z; Ling Y
    Zhonghua Gan Zang Bing Za Zhi; 2000 Dec; 8(6):343-5. PubMed ID: 11135691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron, ferritin, hepatitis B surface and core antigens in the livers of Chinese patients with hepatocellular carcinoma.
    Zhou XD; DeTolla L; Custer RP; London WT
    Cancer; 1987 Apr; 59(8):1430-7. PubMed ID: 3028601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus infection in chronic liver disease in Natal.
    Soni PN; Tait DR; Gopaul W; Sathar MA; Simjee AE
    S Afr Med J; 1996 Jan; 86(1):80-3. PubMed ID: 8685789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.